サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：低分子APIの市場規模、シェア、動向分析レポート：タイプ別（合成、バイオ）、用途別（腫瘍、呼吸器、CNS、内分泌）、メーカー別、地域別、セグメント別予測、2022年～2030年
市場調査レポート
商品コード
1114142

低分子APIの市場規模、シェア、動向分析レポート：タイプ別（合成、バイオ）、用途別（腫瘍、呼吸器、CNS、内分泌）、メーカー別、地域別、セグメント別予測、2022年～2030年

Small Molecule API Market Size, Share & Trends Analysis Report By Type (Synthetic, Biotech), By Application (Oncology, Pulmonology, CNS, Endocrinology), By Manufacturer, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
低分子APIの市場規模、シェア、動向分析レポート：タイプ別（合成、バイオ）、用途別（腫瘍、呼吸器、CNS、内分泌）、メーカー別、地域別、セグメント別予測、2022年～2030年
出版日: 2022年07月05日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

低分子API市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の低分子API市場規模は2030年までに2825億米ドルに達し、予測期間中にCAGR 5.44%で拡大すると予測されています。

世界の医薬品需要の増加と、低分子ベースの新薬承認率の高さがその原動力となっています。

市場に参入する新薬の数は増加しており、主要なプレーヤーにとって有利な機会を生み出しています。例えば、2021年のNCBIによると、FDAに受け入れられた医薬品の75%は低分子であり、治療領域は腫瘍学が支配的でした。これらの承認の50％以上は、CDMOの成長率を高める製品の商業化のためにCDMOのサポートを必要とする中小企業によるものです。

COVID-19の大流行により、低分子原薬の生産拠点がインドや中国などアジアに集中しているため、サプライチェーン上の問題が顕在化しています。そのため、顧客のためにエンド・ツー・エンドで統合されたサプライチェーンを構築することが重視され、そのための政府からのサポートが強化され、欧米諸国での施設数が増加しました。

世界の需要の高まりに対応するため、M&Aが頻繁に行われています。例えば、2022年4月、NovasepとPharmaZellは、複雑な低分子と特殊原薬製造のための主要な技術主導型CDMOを創設するための戦略的合併を発表しました。

市場の拡大や多様化は、市場の主要なプレーヤーがシェアを維持するために用いる重要な戦略となってきています。例えば、2021年4月、ロンザはスイスの低分子用製造コンプレックス建設に2億1860万米ドルの投資計画を発表しました。この施設により、製品の継続的かつ柔軟な供給が可能になると期待されています。

中国、インド、東南アジアなどの新興市場は、大きな成長機会となっています。さらに、中東や東南アジア諸国を中心とした医薬品需要の増加により、「ハラールAPI」などのニッチな分野にも成長機会があると考えられます。合成低分子API分野は、業界の変化する要件に対応する小規模企業やCDMOの存在によって大きく牽引されています。

低分子API市場レポートハイライト

2021年、合成APIは、大量に必要とされる医薬品の製造のための高い需要に起因する最大の市場シェアを占めた

中小企業の商業生産がアウトソーシングに依存していることから、製造委託分野が最大の市場シェアを占めた

がん治療の普及が進み、原薬の需要が高まっていることから、用途別ではがん領域が最も高い成長率を示すと予想される

主要プレイヤーの存在と、同地域のAPI製造能力を強化するための政府からの支援強化により、2021年には北米が市場を独占しました。

目次

第1章 低分子 API市場：調査手法と範囲

  • 市場セグメンテーション
    • セグメントの範囲
    • 地域範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析
      • アプローチ1：コモディティフローアプローチ
      • アプローチ2：ボトムアップアプローチを使用した国別の市場推定
      • アプローチ2：トップダウンアプローチを使用した国別の市場推定
  • 世界市場：CAGR計算
  • 地域市場：CAGR計算
  • 二次情報一覧
  • 目的
  • 略語一覧

第2章 低分子 API市場：エグゼクティブサマリー

  • 低分子 API市場：市場の見通し
    • 市場概要

第3章 低分子 API市場：業界の展望

  • 市場系列の見通し
    • 親市場系統の見通し
    • 関連/補助的な市場の見通し
  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因
      • 製薬産業の高成長
      • 研究開発の増加と新規分子の発売
      • API生産のアウトソーシングの増加
      • 高齢者人口の増加
      • 慢性疾患の蔓延
    • 市場抑制分析
      • 生物製剤の出現
      • アジア諸国への生産依存度が高い
  • SWOT分析、要因別（政治と法律、経済と技術）
  • 業界分析- ポーターズ
  • 償還と規制のシナリオ
  • 主要取引と戦略的提携
    • 新製品の発売
    • 取得
    • 拡張
    • パートナーシップ
    • マーケティングとプロモーション

第4章 低分子 API市場：競合情勢

  • 主要な市場参加者別最近の動向と影響分析
    • Ansoff matrix
  • 会社の分類
    • イノベーター
      • 市場の差別化要因
  • ベンダー情勢
    • 主要なディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2021年
  • 公開会社
    • 競合ダッシュボード分析
  • プライベートカンパニー
    • 主要新興企業一覧
  • 地域ネットワークマップ

第5章 低分子API市場：タイプビジネス分析

  • 低分子API市場：型変動分析
  • 合成
  • バイオテック

第6章 低分子API市場：製品ビジネス分析

  • 低分子API市場：メーカー変動分析
  • 社内
  • 外部委託

第7章 低分子API市場：メーカーのビジネス分析

  • 低分子API市場：メーカー変動分析
  • 心臓病学
  • 腫瘍学
  • 中枢神経系および神経学
  • 整形外科
  • 内分泌学
  • 呼吸器科
  • 消化器科
  • 腎臓学
  • 眼科
  • その他

第8章 低分子API市場：地域ビジネス分析

  • 国別の市場シェア分析、2021年および2030年
    • 北米
      • 米国
      • カナダ
    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
    • アジア太平洋
      • 日本
      • 中国
      • インド
      • 韓国
      • オーストラリア
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
    • 中東とアフリカ
      • 南アフリカ
      • サウジアラビア
      • アラブ首長国連邦

第9章 低分子API市場：企業プロファイリング

  • 企業プロファイル
    • AbbVie, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Bristol-Myers Squibb Company
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Boehringer Ingelheim International GmbH
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Cipla Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Teva Pharmaceutical Industries Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Albemarle Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Viatris Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Aurobindo Pharma
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Sun Pharmaceutical Industries Ltd
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Dr. Reddy's Laboratories Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of Diseases
  • Table 4 Global Small Molecule API Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 Global Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 7 Global Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 8 North America Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 9 North America Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 North America Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 11 North America Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 12 U.S. Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 15 Canada Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 17 Canada Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 18 Europe Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 19 Europe Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 21 Europe Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 22 Germany Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Germany Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 24 Germany Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 25 UK Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 UK Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 27 UK Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 28 France Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 29 France Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 30 France Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 31 Italy Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 Italy Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 Italy Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 34 Spain Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 Spain Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 Spain Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 37 Russia Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 38 Russia Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 39 Russia Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 41 Asia Pacific Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 42 Asia Pacific Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 43 Asia Pacific Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 44 Japan Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 45 Japan Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 Japan Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 47 China Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 48 China Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 49 China Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 50 India Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 India Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 52 India Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 South Korea Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 54 South Korea Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 South Korea Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 56 Australia Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 Australia Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 58 Australia Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 59 Latin America Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 60 Latin America Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 61 Latin America Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 62 Latin America Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 63 Brazil Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 64 Brazil Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 65 Brazil Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 66 Mexico Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 67 Mexico Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 68 Mexico Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 69 Argentina Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 70 Argentina Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 71 Argentina Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 72 Middle East & Africa Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 73 Middle East & Africa Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 74 Middle East & Africa Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 75 Middle East & Africa Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 76 Saudi Arabia Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 77 Saudi Arabia Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 78 Saudi Arabia Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 79 South Africa Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 80 South Africa Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 81 South Africa Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 82 UAE Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 UAE Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 84 UAE Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Small molecule API market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021, (USD Billion)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Small molecule API market driver impact
  • Fig. 14 Small molecule API market restraint impact
  • Fig. 15 SWOT analysis, by a factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Small molecule API market - Unmet needs analysis
  • Fig. 19 Small molecule API market: Type outlook and key takeaways
  • Fig. 20 Small molecule API market: Type movement analysis & market share 2021 & 2030
  • Fig. 21 Synthetic market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Biotech market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Small molecule API market: manufacturer outlook and key takeaways
  • Fig. 24 Small molecule API market: manufacturer movement analysis & market share 2021 & 2030
  • Fig. 25 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Small molecule API market: application outlook and key takeaways
  • Fig. 28 Small molecule API market: application movement analysis & market share 2021 & 2030
  • Fig. 29 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 CNS and neurology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 Other market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Small molecule API: Regional outlook and key takeaways
  • Fig. 40 Regional outlook, 2021 & 2030
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Europe
  • Fig. 48 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 UK
  • Fig. 50 UK market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 France
  • Fig. 54 France market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Russia
  • Fig. 60 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Asia-Pacific
  • Fig. 62 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Japan
  • Fig. 64 Japan market estimates and forecast, 2018 - 2030(USD Billion)
  • Fig. 65 China
  • Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 67 India
  • Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 69 South Korea
  • Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 71 Australia
  • Fig. 72 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 73 Latin America
  • Fig. 74 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 75 Brazil
  • Fig. 76 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 77 Mexico
  • Fig. 78 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 79 Argentina
  • Fig. 80 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 81 Middle East & Africa
  • Fig. 82 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 83 South Africa
  • Fig. 84 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 85 Saudi Arabia
  • Fig. 86 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 87 UAE
  • Fig. 88 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 89 Ansoff Matrix
  • Fig. 90 Market differentiators
  • Fig. 91 Key company market share analysis, 2021
  • Fig. 92 Company market position analysis
  • Fig. 93 Competitive dashboard analysis
  • Fig. 94 Regional network map
目次
Product Code: GVR-4-68039-952-0

Small Molecule API Market Growth & Trends:

The global small molecule API market size is expected to reach USD 282.50 billion by 2030, expanding at a CAGR of 5.44% during the forecast period, according to a new report by Grand View Research, Inc. It is driven by an increase in demand for pharmaceuticals globally and a high rate of new small molecule-based drug approval.

The increasing number of new pharmaceuticals entering the market is creating a lucrative opportunity for key players. For instance, as per NCBI in 2021, 75% of the drugs accepted by the FDA were small molecules, with the dominant therapeutic area being oncology. Over 50% of these approvals were from small and mid-sized companies which require support from CDMOs for the commercialization of products that enhance the growth rate of CDMOs.

The COVID-19 pandemic has made supply-chain shortcomings in the small-molecule API business apparent, as most of the production facilities are located in Asian nations such as India and China. This has increased the focus of players on creating an end-to-end integrated supply chain for the clients and increased the number of facilities in western countries with heightened support from the government for doing the same.

Merger and acquisition activities are frequently being undertaken by the players to meet the soaring demands globally. For instance, in April 2022, Novasep and PharmaZell announced a strategic merger for the creation of a leading technologically-driven CDMO for complex small molecules and specialty API production.

Expansion and diversification are becoming key strategies used by key players in the market to maintain their market share. For instance, in April 2021, Lonza announced its investment plan of USD 218.6 million for the construction of a manufacturing complex for small molecules in Switzerland. The facility is expected to ensure continuity and flexibility of supply for the products.

Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth. Furthermore, niche areas such as "halal API" further present growth opportunities owing to the rise in the demand for drugs in the segment, majorly in Middle Eastern and Southeast Asian nations. The synthetic small molecule API segment is largely driven by the presence of small companies and CDMOs that cater to the changing requirements of the industry.

Small Molecule API Market Report Highlights:

  • In 2021, synthetic APIs held the largest market share attributable to the high demand for the production of pharmaceuticals that are required in high volume
  • The outsourced manufacturing segment held the largest market share owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • Oncology is projected to grow at the fastest rate in the application segment as the adoption of cancer treatments is rising, creating a strong demand for API
  • North America dominated the market in 2021 due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region

Table of Contents

Chapter 1 Small Molecule API Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
      • 1.6.1.3 Approach 2: Country-Wise Market Estimation Using Top-Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 Small Molecule API Market: Executive Summary

  • 2.1 Small Molecule API Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Small Molecule API Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 High growth of the pharmaceutical industry
      • 3.3.1.2 Rising R&D and launch of novel molecules
      • 3.3.1.3 Increased outsourcing of API production
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Escalating prevalence of chronic diseases
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Emergence of biologics
      • 3.3.2.2 High dependence on Asian nations for production
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Small Molecule API Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive dashboard analysis
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Regional Network Map

Chapter 5 Small Molecule API Market: Type Business Analysis

  • 5.1 Small Molecule API Market: Type Movement Analysis
  • 5.2 Synthetic
    • 5.2.1 Synthetic market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.3 Biotech
    • 5.3.1 Biotech market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 6 Small Molecule API Market: Product Business Analysis

  • 6.1 Small Molecule API Market: Manufacturer Movement Analysis
  • 6.2 In-house
    • 6.2.1 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.3 Outsourced
    • 6.3.1 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 7 Small Molecule API Market: Manufacturer Business Analysis

  • 7.1 Small Molecule API Market: Manufacturer Movement Analysis
  • 7.2 Cardiology
    • 7.2.1 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.3 Oncology
    • 7.3.1 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.4 CNS and Neurology
    • 7.4.1 CNS and Neurology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.5 Orthopedic
    • 7.5.1 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.6 Endocrinology
    • 7.6.1 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.7 Pulmonology
    • 7.7.1 Pulmunology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.8 Gastroenterology
    • 7.8.1 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.9 Nephrology
    • 7.9.1 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.10 Opthalmology
    • 7.10.1 Opthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.11 Others
    • 7.11.1 Other market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Small Molecule API Market: Regional Business Analysis

  • 8.1 Market Share Analysis by Country, 2021 & 2030
    • 8.1.1 North America
      • 8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.1.2 U.S.
      • 8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.1.3 Canada
      • 8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.2 Europe
      • 8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.2 UK
      • 8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.3 Germany
      • 8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.4 France
      • 8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.5 Italy
      • 8.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.6 Spain
      • 8.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.3 Asia-Pacific
      • 8.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.2 Japan
      • 8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.3 China
      • 8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.4 India
      • 8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.5 South Korea
      • 8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.6 Australia
      • 8.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.4 Latin America
      • 8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.4.2 Brazil
      • 8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.4.3 Mexico
      • 8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.4.4 Argentina
      • 8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.5 Middle East and Africa
      • 8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.5.2 South Africa
      • 8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.5.3 Saudi Arabia
      • 8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.5.4 UAE
      • 8.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 9 Small Molecule API Market: Company Profiling

  • 10.1 Company Profiles
    • 10.1.1 AbbVie, Inc.
      • 10.1.1.1 Company Overview
      • 10.1.1.2 Financial Performance
      • 10.1.1.3 Product Benchmarking
      • 10.1.1.4 Strategic Initiatives
    • 10.1.2 Bristol-Myers Squibb Company
      • 10.1.2.1 Company Overview
      • 10.1.2.2 Financial Performance
      • 10.1.2.3 Product Benchmarking
      • 10.1.2.4 Strategic Initiatives
    • 10.1.3 Boehringer Ingelheim International GmbH
      • 10.1.3.1 Company Overview
      • 10.1.3.2 Financial Performance
      • 10.1.3.3 Product Benchmarking
      • 10.1.3.4 Strategic Initiatives
    • 10.1.4 Cipla Inc.
      • 10.1.4.1 Company Overview
      • 10.1.4.2 Financial Performance
      • 10.1.4.3 Product Benchmarking
      • 10.1.4.4 Strategic Initiatives
    • 10.1.5 Teva Pharmaceutical Industries Ltd.
      • 10.1.5.1 Company Overview
      • 10.1.5.2 Financial Performance
      • 10.1.5.3 Product Benchmarking
      • 10.1.5.4 Strategic Initiatives
    • 10.1.6 Albemarle Corporation
      • 10.1.6.1 Company Overview
      • 10.1.6.2 Financial Performance
      • 10.1.6.3 Product Benchmarking
      • 10.1.6.4 Strategic Initiatives
    • 10.1.7 Viatris Inc.
      • 10.1.7.1 Company Overview
      • 10.1.7.2 Financial Performance
      • 10.1.7.3 Product Benchmarking
      • 10.1.7.4 Strategic Initiatives
    • 10.1.8 Aurobindo Pharma
      • 10.1.8.1 Company Overview
      • 10.1.8.2 Financial Performance
      • 10.1.8.3 Product Benchmarking
      • 10.1.8.4 Strategic Initiatives
    • 10.1.9 Sun Pharmaceutical Industries Ltd
      • 10.1.9.1 Company Overview
      • 10.1.9.2 Financial Performance
      • 10.1.9.3 Product Benchmarking
      • 10.1.9.4 Strategic Initiatives
    • 10.1.10 Dr. Reddy's Laboratories Ltd.
      • 10.1.10.1 Company Overview
      • 10.1.10.2 Financial Performance
      • 10.1.10.3 Product Benchmarking
      • 10.1.10.4 Strategic Initiatives